Biotechnology Company in California

Auction Sale of substantially all of assets of the uBiome, Inc., including but not limited to the inventory, receivables, equipment, intellectual property, unexpired leases, contract rights and other assets related to or necessary to operate the gastro-intestinal microbe DNA sequencing business currently operated by the seller (collectively, the “Assets”), and more described as below:

• The seller's San Francisco lab, which is certified by both the State of California and the Center for Medicare and Medicaid Services under the Clinical Laboratory Improvement Amendments (“CLIA”) regulations and accredited by the College of American Pathologists (“CAP”). Only 3% of labs in the U.S. have the CLIA and CAP designations, giving uBiome a significant competitive advantage, a path to monetize its lab capabilities, and a barrier to entry which is expensive to duplicate;
• The Santiago, Chile R&D facility and team, which has deep experience and proprietary know-how with technologies related to gene sequencing of microbial samples, bioinformatics analysis to analyze and identify associations between microbes and health conditions, developing machine-learning based analytics for medical conditions, and automatic lab processes for high volume sample testing;
• Strong medical affairs team with research expertise in various aspects of the human microbiome;
• The engineering team in Argentina with deep expertise in creating production software for biotechnology applications, and laboratory information management software integrating wet and dry lab processes;
• A strong portfolio of documented associations between specific microbes and disorders, including HPV, STD’s, and Irritable Bowel Syndrome / Disorder;
• In-house expertise in the form of trade secrets with respect to various gene sequencing technologies;
• The largest sample data base in the industry of nearly 300,000 samples, over 8,000 of which have metadata;
• A portfolio of over 45 patents, with particular strength in wet-and dry-lab methodology and associations demonstrating the Debtor’s strength with academic and corporate partners;
• A highly qualified, experienced team with deep academic training and commercial experience that would take significant time and resources to re-assemble; and
• A strong reputation in the industry and academia for the quality of its people and capabilities.